Overview

* Owens & Minor ( OMI ) Q2 revenue from continuing ops rises, but misses analysts' expectations

* Adjusted EPS for Q2 misses consensus

* Co classifies Products & Healthcare Services segment as discontinued operations

Outlook

* Company to provide 2025 financial outlook during earnings call

* Owens & Minor ( OMI ) focuses on Patient Direct segment post-divestiture

* Company confident in leading evolving market with favorable trends

Result Drivers

* PATIENT DIRECT FOCUS - Co emphasizes transition to pure-play Patient Direct business, citing favorable demographic trends and scale

* DISCONTINUED OPERATIONS - Products & Healthcare Services segment classified as discontinued due to impending sale

* REVENUE GROWTH - Revenue from continuing operations increased compared to prior year, driven by Patient Direct segment

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Miss $681.90 $2.73

Revenue mln bln (6

Analysts

)

Q2 Miss $0.26 $0.27 (6

Adjusted Analysts

EPS )

Q2 Net -$869.06

Income mln

Q2 Miss $96.60 $128.80

Adjusted mln mln (6

EBITDA Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and 2 "sell" or "strong sell"

* The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

* Wall Street's median 12-month price target for Owens & Minor Inc ( OMI ) is $10.00, about 29.1% above its August 8 closing price of $7.09

* The stock recently traded at 4 times the next 12-month earnings vs. a P/E of 4 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)